Abacus Global Management (ABX) investor relations material

Executive summary

• Achieved record Q2 2026 revenue of $73 million, up 30% year-over-year, with adjusted net income of $27.1 million and adjusted EBITDA of $39.9 million, both exceeding guidance.

• Raised $544.2 million in longevity fund inflows in H1 2026, surpassing the $500 million target and nearly matching all of 2025.

• Launched the ABX Longevity Growth and Income Fund, the first registered interval fund for the longevity asset class, expanding access for individual investors.

• Integrated Manning & Napier through a $53 million minority investment, establishing referral channels and rolling out LifeARC across their advisor network.

• Initiated tokenization of in-force life insurance policies to enhance transparency and liquidity in the secondary market.

Financial highlights

• Q2 2026 revenue grew 30% year-over-year to $73 million, driven by 38.3% growth in Life Solutions to $65.4 million.

• Adjusted net income was $27.1 million ($0.28 per diluted share), above Q2 guidance; adjusted EBITDA reached $39.9 million, up 27% year-over-year, with a 54.7% margin.

• GAAP net income for Q2 2026 was $6.6 million, down from $17.6 million in Q2 2025, due to higher operating expenses and acquisition-related costs.

• Cash balance at quarter-end was $23.4 million; policy assets totaled $383 million; long-term debt at $330.6 million.

• Operating cash flow for the first half of 2026 was $130.9 million, up from $14.5 million in the prior-year period.

Outlook and guidance

• Q3 2026 guidance: adjusted net income of $26–$28 million and adjusted EPS of $0.26–$0.28.

• Full-year 2026 guidance: adjusted net income of $100–$106 million and adjusted EPS of $1.00–$1.05, implying up to 24% year-over-year growth.

• Capital deployed expected to rise to $150–$175 million in Q3, above prior $130–$150 million range.

• Management expects continued growth in life solutions and technology services, supported by expanded capital and new fund launches.

• Targeting $5 billion in AUM by year-end 2026, driven by longevity and interval funds.